Europe’s sleep apnea therapeutic devices market is expected to add more than USD 720 Million in value during 2026–2031.

  • Historical Period: 2020-2024
  • Base Year: 2025
  • Forecast Period: 2026-2031
  • Largest Market: Germany
  • Fastest Market: Spain
  • Format: PDF & Excel
Featured Companies
  • 1 . ResMed
  • 2 . Fisher & Paykel Healthcare Corporation Limited
  • 3 . Koninklijke Philips
  • 4 . GE Healthcare
  • 5 . Invacare Corporation
  • 6 . Sonova Holding AG
  • More...

Sleep Apnea Therapeutic Devices Market Analysis

The development of the Europe Sleep Apnea Treatment Devices sector shows the region's significant focus on ensuring everyone has access to healthcare, preventive measures, and clinical practices rooted in evidence, especially within predominantly public health systems. This market aims to detect, manage, and treat sleep-related breathing issues, notably obstructive sleep apnea OSA, to minimize risks associated with long-term cardiovascular, metabolic, and cognitive health. The market encompasses hospitals, sleep research facilities, home care providers, and increasingly primary care options, matching Europe's preventive care model that emphasizes early detection and long-term management of diseases. Devices for sleep apnea made their debut in Europe many years ago, initially relying on polysomnography for diagnosis and continuous positive airway pressure CPAP therapy in dedicated sleep clinics. Over the years, improvements in comfort, noise reduction, and automation of devices have led to wide adoption in hospitals and recognized sleep centers, followed by significant growth in home therapy setups. In terms of technology, this market includes CPAP, BiPAP, APAP devices, oral devices, adaptive servo-ventilation, and integrated monitoring solutions. These technologies work to keep the airway clear during sleep, enhancing oxygen levels, reducing apnea-hypopnea occurrences, and greatly improving patient outcomes, daily alertness, and life quality. Research and development initiatives sourced from the EU, propelled by Horizon programs and partnerships between public and private sectors, have accelerated advancements in digital health, data analysis, and remote patient tracking. Goals for sustainability promote energy-efficient devices, reusable parts, and responsible production methods. According to the research report, " Europe Sleep Apnea Therapeutic Devices Market Research Report, 2031," published by Actual Market Research, the Europe Sleep Apnea Therapeutic Devices market is anticipated to add to more than USD 720 Million by 2026-31. This expansion is bolstered by changes in regulations, including the full enforcement of the MDR, which, despite raising compliance expenses, has enhanced trust in the market and promoted innovation in higher-quality products.

Recent advancements feature quieter and more compact CPAP equipment, AI-driven therapy optimization, cloud-based compliance tracking, and patient-focused mask designs that enhance adherence to treatment. Key local and international players actively competing in this field include ResMed, Philips Respironics, Löwenstein Medical, Fisher & Paykel Healthcare, and Drive DeVilbiss Healthcare. These firms provide a diverse range of offerings, from diagnostic tools and PAP devices to masks, humidifiers, and digital therapy systems, competing based on clinical effectiveness, patient comfort, connectivity, and integrated service. Market prospects are increasing due to an aging population in Europe, which experiences a higher incidence of sleep apnea and associated chronic illnesses. Growing awareness among healthcare providers and patients, aided by public health initiatives and professional sleep organizations, is raising diagnostic rates. Government-assisted healthcare schemes and reimbursement policies in nations like Germany, France, and the Nordic countries encourage early treatment and adherence to long-term therapy, establishing sleep apnea treatment devices as an essential aspect of Europe’s preventive and value-oriented healthcare system. .

What's Inside a Actual Market Research`s industry report?

Asia-Pacific dominates the market and is the largest and fastest-growing market in the animal growth promoters industry globally

Download Sample
Report Sample Preview

Market Dynamic

Market Drivers

• Aging demographics and rising awareness of diseases: Europe is experiencing a significant increase in its aging population, leading to a higher occurrence of sleep apnea. The elderly are more vulnerable to disorders related to respiration and sleep. A growing understanding of the connection between sleep apnea and heart issues has led to better diagnosis. Public health initiatives and doctor training are crucial in this process. More patients are actively pursuing treatment to enhance their well-being. Early treatment is becoming a healthcare priority. All these elements collectively drive the need for treatment devices.

• Strong public healthcare systems and clinical protocols: Countries in Europe enjoy robust public healthcare systems that facilitate uniform diagnosis and treatment of sleep apnea. Clinical protocols endorse the evidence-based application of therapeutic devices. Numerous healthcare systems provide coverage for sleep apnea treatments, promoting usage. Hospitals and sleep centers are well-connected within national health infrastructures. Standardized practices enhance treatment uniformity across different regions. Public financing aids in managing diseases over the long term. This organized method fosters consistent market demand. Market Challenges

• Strict EU Medical Device Regulation MDR standards: The adoption of the EU Medical Device Regulation MDR has made regulatory requirements more complex for manufacturers. Meeting these standards necessitates detailed clinical data, documentation, and post-market monitoring. Such mandates escalate development expenses and prolong product release timelines. Smaller manufacturers encounter steeper challenges entering the market. The process of regulation has led to temporary product availability issues. Companies are required to invest significantly in compliance knowledge. This situation affects both the timing of innovation and the expansion of the market.

• Discrepancies in reimbursement across European nations: The policies regarding reimbursement for sleep apnea devices vary greatly among European nations. Some countries provide full coverage, while others only offer limited or partial reimbursement. This lack of consistency impacts patient access and the rates of adoption. Financial limitations within public healthcare systems further restrict the availability of devices. Manufacturers face complications in navigating pricing strategies that differ by country. The unequal reimbursement landscape results in fragmentation of the market. Tackling the challenge of policy alignment is essential. Market Trends

• Movement towards home-based sleep evaluation and treatment: European health systems are increasingly advocating for home-based sleep evaluations and treatment. This method alleviates the pressure on hospitals and reduces health expenses. Patients gain from greater convenience and quicker diagnoses. Home treatment fits well with initiatives focused on value-based care. Technological advancements enable reliable monitoring at home. The trend is particularly strong in Western Europe. This shift is transforming conventional approaches to sleep care.

• Increasing use of digital monitoring technologies: Digital analysis tools are becoming popular in Europe to enhance adherence to therapy. Connected devices allow doctors to monitor patient progress from a distance. Data analysis supports individualized treatment strategies. Digital solutions lead to better long-term health results. Integration with electronic health records improves coordination of care.
Make this report your own

We're excited to discuss your needs and our solutions. Let's schedule a call.

Manmayi Raval
Manmayi Raval

Analyst

Sleep Apnea Therapeutic DevicesSegmentation

By Product Type Positive Airway Pressure (PAP) Devices
Oral Appliances (Mandibular Advancement Devices - MADs)
Adaptive Servo-Ventilators (ASV)
Nasal Devices (Expiratory Positive Airway Pressure - EPAP)
Accessories & Consumables
Diagnostic Devices & others
By Indication Obstructive Sleep Apnea (OSA)
Central Sleep Apnea (CSA)
Mixed/Complex Sleep Apnea
By End-User Home Care Settings / Individuals
Sleep Laboratories & Clinics
Hospitals
By Distribution Channel Direct Sales
Retail & Online Sales
Home Care Providers / Durable Medical Equipment (DME) Suppliers
Europe North America
Europe
Asia-Pacific
South America
MEA



EPAP nasal devices are experiencing rapid growth in Europe due to their non-invasive nature, ease of transport, and a strong match with patient preferences for straightforward, at-home treatments.

Nasal devices that operate on Expiratory Positive Airway Pressure EPAP represent the rapidly expanding segment within the European sleep apnea treatment market. This growth is largely driven by the focus of European healthcare systems on enhancing patient comfort, encouraging adherence, and promoting affordable long-term care. In contrast to conventional PAP machines, EPAP devices are compact, either disposable or reusable nasal valves that function without electricity or intricate hardware. This simplicity is especially appealing to patients experiencing mild to moderate obstructive sleep apnea or those who cannot tolerate CPAP therapy. Europe's strong commitment to preventive health care and early treatment fosters the preference for less complicated therapies prior to resorting to more advanced solutions. Moreover, many patients in Europe appreciate solutions that are discreet, convenient for travel, and quiet, which fits well into their daily routines, thus pushing the demand for EPAP devices. Increased regulatory clarity provided by CE marking and MDR has bolstered clinical trust in these devices, while accumulating clinical data backs their efficacy for specific patient groups. Public healthcare systems and healthcare providers find EPAP devices appealing because of their lower initial costs, minimal upkeep, and lesser requirement for ongoing technical assistance. A growing awareness of sleep disorders, alongside rising rates of diagnoses through home sleep tests, has widened the market for alternative treatments. The aging population in Europe and their inclination toward home-based care options are driving further adoption. All these clinical, economic, and lifestyle benefits make EPAP nasal devices the most rapidly growing segment in the European sleep apnea therapeutic device market.

Mixed/Complex Sleep Apnea represents the segment with the fastest growth in the European market for sleep apnea treatment devices due to enhanced diagnostic skills and greater recognition of coexisting obstructive and central sleep apnea conditions.

In Europe, the category of Mixed or Complex Sleep Apnea is becoming the most rapidly expanding segment in the market for sleep apnea treatment devices. This growth is primarily influenced by better diagnostic accuracy and a deeper clinical understanding of sleep-related breathing issues. Mixed sleep apnea, which includes both obstructive and central sleep apnea events, has often been underdiagnosed due to restrictions in traditional sleep assessments. Nonetheless, the rise in the use of advanced polysomnography, adaptive servo-ventilation ASV, and digitally driven diagnostic methods throughout European healthcare systems has enhanced the detection of more complicated cases. The aging population in Europe significantly contributes to this trend, as older adults are more susceptible to neurological, cardiovascular, and respiratory ailments that lead to central and mixed sleep apnea. Moreover, the higher rates of heart failure, stroke, and neurodegenerative diseases in Europe have increased the importance of addressing mixed sleep apnea. Clinicians in Europe are increasingly favoring personalized and precision-focused treatment methods, necessitating different therapies rather than just standard CPAP, which is driving up the need for more advanced therapeutic devices. The alignment of regulatory standards with EU clinical guidelines has also enhanced the uniformity of diagnosis and treatment protocols. Growing recognition among healthcare professionals about the limits of conventional OSA treatments for complex cases has prompted a transition towards specialized devices like ASV systems. These aspects, along with robust public healthcare backing for managing chronic diseases, position Mixed/Complex Sleep Apnea as the most rapidly expanding segment in the European sleep apnea treatment device market.

Home care environments and individual patients are the largest and most rapidly advancing segment of end-users in Europe due to strategies aimed at controlling healthcare costs, strong public health system support, and rising acceptance of home-based management for chronic diseases.

In Europe, home care environments and individual patients are at the forefront of the sleep apnea treatment device market as healthcare systems focus on cost-effectiveness and managing chronic conditions beyond hospital settings. Public health providers across the continent advocate for home therapy to alleviate inpatient overcrowding and manage escalating healthcare costs. Sleep apnea is acknowledged as a long-term condition requiring consistent treatment, making the home use of therapeutic devices the most practical care approach. Innovations in medical device development have increased comfort, portability, and user-friendliness, motivating patients to manage their therapy themselves at home. Numerous European nations offer reimbursement or subsidized access to home-use sleep apnea devices, facilitating widespread adoption. The rise of digital health initiatives and remote patient monitoring empowers healthcare providers to track therapy adherence without the need for frequent office visits. The aging population and heightened awareness of cardiovascular risks related to sleep further propel the demand for sustained home therapy. Therefore, home care environments and individual patients persistently grow, establishing themselves as the leading end-user segment in the European sleep apnea treatment device market.

Home care providers and DME suppliers lead in Europe because of public healthcare payment systems and a strong focus on clinician-supervised, long-term home treatment.

Home care providers and Durable Medical Equipment DME suppliers are the main distribution channel in the sleep apnea therapy device market in Europe because healthcare systems there favor coordinated treatment plans supervised by clinicians at home. In several EU nations, therapies for sleep apnea are prescribed, provided, and overseen by national or regional healthcare services that depend on certified DME suppliers to furnish devices, guide patients, and support adherence. In countries like Germany, France, the UK, and the Nordic region, the reimbursement systems are designed around long-term rentals or service-based models instead of direct purchases by consumers, which emphasizes the importance of home care suppliers. These suppliers handle device fitting, selection of masks, upkeep, and monitoring of data, which aligns with Europe’s focus on ensuring quality and safety for patients. Strong connections with hospitals and sleep centers guarantee a smooth transition of care from diagnosis through therapy commencement and follow-up. Furthermore, Europe’s growing elderly population and the increasing occurrence of chronic respiratory illnesses amplify the need for professional home assistance. DME suppliers also play an important role in managing CE-marked devices, ensuring compliance with the MDR, and adhering to cross-border procurement regulations, which helps lessen the administrative workload for both patients and healthcare providers. Their capacity to provide tailored, regulated, and reimbursed services on a large scale establishes home care providers and DME suppliers as the most reliable and recognized distribution channel within the European sleep apnea therapeutic devices sector.

Sleep Apnea Therapeutic Devices Market Regional Insights


Germany stands out in the European sleep apnea treatment device market due to its robust public health system, early embrace of sleep medicine, advanced diagnostic facilities, and extensive reimbursement support.

Germany occupies a top place in the European market for sleep apnea treatment devices, backed by its efficient healthcare system and a strong focus on early diagnosis and managing chronic illnesses. The nation features one of the most sophisticated sleep medicine frameworks in Europe, with a dense network of certified sleep laboratories and specialized breathing clinics. There is a high level of awareness about sleep apnea among healthcare professionals, which helps in the prompt detection and treatment of both obstructive and complicated sleep apnea cases. Germany was also one of the first to adopt CPAP and BiPAP treatments and continues to support technological developments like adaptive servo-ventilation and interconnected devices. A crucial reason for Germany’s market lead is its extensive public health insurance system, which offers significant coverage for sleep apnea testing and treatment devices, ensuring that patients have good access and adherence. Furthermore, Germany acts as a central point for medical device production and research in Europe, featuring numerous top and regional companies that invest significantly in innovation and clinical testing. The country's strong commitment to regulatory standards and its alignment with EU medical device regulations further enhance product safety and quality. Alongside an aging demographic and a growing rate of heart and lung diseases, these elements collectively solidify Germany’s status as the foremost market for sleep apnea therapeutic devices in Europe.

Companies Mentioned

  • 1 . ResMed
  • 2 . Fisher & Paykel Healthcare Corporation Limited
  • 3 . Koninklijke Philips
  • 4 . GE Healthcare
  • 5 . Invacare Corporation
  • 6 . Sonova Holding AG
  • 7 . Starkey Hearing Technologies
  • 8 . Drive DeVilbiss Healthcare
  • 9 . Nihon Kohden Corporation
  • 10 . LivaNova PLC
  • 11 . Nyxoah SA
  • 12 . Medtronic plc
Company mentioned

Table of Contents

  • Table 1: Influencing Factors for Sleep Apnea Therapeutic Devices Market, 2025
  • Table 2: Top 10 Counties Economic Snapshot 2024
  • Table 3: Economic Snapshot of Other Prominent Countries 2022
  • Table 4: Average Exchange Rates for Converting Foreign Currencies into U.S. Dollars
  • Table 5: Europe Sleep Apnea Therapeutic Devices Market Size and Forecast, By Product Type (2020 to 2031F) (In USD Billion)
  • Table 6: Europe Sleep Apnea Therapeutic Devices Market Size and Forecast, By Indication (2020 to 2031F) (In USD Billion)
  • Table 7: Europe Sleep Apnea Therapeutic Devices Market Size and Forecast, By End-User (2020 to 2031F) (In USD Billion)
  • Table 8: Europe Sleep Apnea Therapeutic Devices Market Size and Forecast, By Distribution Channel (2020 to 2031F) (In USD Billion)
  • Table 9: Germany Sleep Apnea Therapeutic Devices Market Size and Forecast By Product Type (2020 to 2031F) (In USD Billion)
  • Table 10: Germany Sleep Apnea Therapeutic Devices Market Size and Forecast By Indication (2020 to 2031F) (In USD Billion)
  • Table 11: Germany Sleep Apnea Therapeutic Devices Market Size and Forecast By End-User (2020 to 2031F) (In USD Billion)
  • Table 12: United Kingdom (UK) Sleep Apnea Therapeutic Devices Market Size and Forecast By Product Type (2020 to 2031F) (In USD Billion)
  • Table 13: United Kingdom (UK) Sleep Apnea Therapeutic Devices Market Size and Forecast By Indication (2020 to 2031F) (In USD Billion)
  • Table 14: United Kingdom (UK) Sleep Apnea Therapeutic Devices Market Size and Forecast By End-User (2020 to 2031F) (In USD Billion)
  • Table 15: France Sleep Apnea Therapeutic Devices Market Size and Forecast By Product Type (2020 to 2031F) (In USD Billion)
  • Table 16: France Sleep Apnea Therapeutic Devices Market Size and Forecast By Indication (2020 to 2031F) (In USD Billion)
  • Table 17: France Sleep Apnea Therapeutic Devices Market Size and Forecast By End-User (2020 to 2031F) (In USD Billion)
  • Table 18: Italy Sleep Apnea Therapeutic Devices Market Size and Forecast By Product Type (2020 to 2031F) (In USD Billion)
  • Table 19: Italy Sleep Apnea Therapeutic Devices Market Size and Forecast By Indication (2020 to 2031F) (In USD Billion)
  • Table 20: Italy Sleep Apnea Therapeutic Devices Market Size and Forecast By End-User (2020 to 2031F) (In USD Billion)
  • Table 21: Spain Sleep Apnea Therapeutic Devices Market Size and Forecast By Product Type (2020 to 2031F) (In USD Billion)
  • Table 22: Spain Sleep Apnea Therapeutic Devices Market Size and Forecast By Indication (2020 to 2031F) (In USD Billion)
  • Table 23: Spain Sleep Apnea Therapeutic Devices Market Size and Forecast By End-User (2020 to 2031F) (In USD Billion)
  • Table 24: Russia Sleep Apnea Therapeutic Devices Market Size and Forecast By Product Type (2020 to 2031F) (In USD Billion)
  • Table 25: Russia Sleep Apnea Therapeutic Devices Market Size and Forecast By Indication (2020 to 2031F) (In USD Billion)
  • Table 26: Russia Sleep Apnea Therapeutic Devices Market Size and Forecast By End-User (2020 to 2031F) (In USD Billion)
  • Table 27: Competitive Dashboard of top 5 players, 2025

  • Figure 1: Europe Sleep Apnea Therapeutic Devices Market Size By Value (2020, 2025& 2031F) (in USD Billion)
  • Figure 2: Europe Sleep Apnea Therapeutic Devices Market Share By Country (2025)
  • Figure 3: Germany Sleep Apnea Therapeutic Devices Market Size By Value (2020, 2025& 2031F) (in USD Billion)
  • Figure 4: United Kingdom (UK) Sleep Apnea Therapeutic Devices Market Size By Value (2020, 2025& 2031F) (in USD Billion)
  • Figure 5: France Sleep Apnea Therapeutic Devices Market Size By Value (2020, 2025& 2031F) (in USD Billion)
  • Figure 6: Italy Sleep Apnea Therapeutic Devices Market Size By Value (2020, 2025& 2031F) (in USD Billion)
  • Figure 7: Spain Sleep Apnea Therapeutic Devices Market Size By Value (2020, 2025& 2031F) (in USD Billion)
  • Figure 8: Russia Sleep Apnea Therapeutic Devices Market Size By Value (2020, 2025& 2031F) (in USD Billion)
  • Figure 9: Porter's Five Forces of Global Sleep Apnea Therapeutic Devices Market

Sleep Apnea Therapeutic Devices Market Research FAQs

Factors such as a rising awareness of sleep disorders, an aging population, and advancements in technology for sleep apnea diagnosis and treatment may contribute to market growth.
Sleep apnea is recognized as a common sleep disorder in Europe. Diagnosis often involves sleep studies, which can be conducted in sleep centers or through home sleep apnea testing.
Common devices include Continuous Positive Airway Pressure (CPAP) machines, Bi-level Positive Airway Pressure (BiPAP) machines, oral appliances, and adaptive servo-ventilation devices.
Anticipated trends may include advancements in device miniaturization, increased connectivity for remote monitoring, and the integration of artificial intelligence for personalized therapy.
Patient education, follow-up care, and the use of data monitoring technologies are strategies to encourage and monitor compliance with sleep apnea therapy.
Growth is driven by an aging population, increasing awareness of sleep issues, the rise of sleep laboratories, preventive healthcare approaches, and robust public health systems.
Home care providers and Durable Medical Equipment DME suppliers represent the largest distribution channel due to service models reliant on reimbursement.
EU regulations, including CE marking and adherence to the Medical Device Regulation MDR, improve patient safety, product quality, and traceability.
Important trends include the rise of home-based care, greater use of EPAP and oral devices, digital monitoring options, environmentally friendly device designs.

Why Actual Market Research?

  • Our seasoned industry experts bring diverse sector experience, tailoring methodologies to your unique challenges.
  • Leveraging advanced technology and time-tested methods ensures accurate and forward-thinking insights.
  • Operating globally with a local touch, our research spans borders for a comprehensive view of international markets.
  • Timely and actionable insights empower swift, informed decision-making in dynamic market landscapes.
  • We foster strong client relationships based on trust, transparency, and collaboration.
  • Our dedicated team adapts and evolves strategies to meet your evolving needs.
  • Upholding the highest standards of ethics and data security, we ensure confidentiality and integrity throughout the research process.

How client has rates us?

Requirement Gathering & Methodology 92%
Data Collection Techniques 97%
Our Research Team & Data Sourcing 93%
Data Science & Analytical Tools 81%
Data Visualization & Presentation Skills 86%
Project/ Report Delivery & After Sales Services 88%

Related Tags